| scholarly article | Q13442814 |
| P50 | author | Nicholas John White | Q21166848 |
| François Nosten | Q28033645 | ||
| Moo Kho Paw | Q55979715 | ||
| Pratap Singhasivanon | Q37391387 | ||
| P2093 | author name string | S J Lee | |
| Oh Mu | |||
| M J Rijken | |||
| R McGready | |||
| J A Simpson | |||
| M Boel | |||
| M K Paw | |||
| M Pimanpanarak | |||
| E A Ashley | |||
| J Wiladphaingern | |||
| P2860 | cites work | The safety of artemisinins during pregnancy: a pressing question | Q27497231 |
| The safety of the combination artesunate and pyrimethamine-sulfadoxine given during pregnancy | Q43752865 | ||
| Artemisinin antimalarials in pregnancy: a prospective treatment study of 539 episodes of multidrug-resistant Plasmodium falciparum | Q43801610 | ||
| Artemisinin derivatives in the treatment of falciparum malaria in pregnancy | Q44514584 | ||
| Safety of artemisinins during early pregnancy, assessed in 62 Sudanese women | Q46063962 | ||
| Mefloquine prophylaxis prevents malaria during pregnancy: a double-blind, placebo-controlled study | Q46364500 | ||
| Bed nets for the prevention of malaria and anaemia in pregnancy | Q46365244 | ||
| Artesunate: developmental toxicity and toxicokinetics in monkeys | Q46430581 | ||
| Sensitive periods for developmental toxicity of orally administered artesunate in the rat. | Q46491873 | ||
| A double-blind randomized therapeutic trial of insect repellents for the prevention of malaria in pregnancy | Q47883135 | ||
| Low seroprevalence of HIV and syphilis in pregnant women in refugee camps on the Thai-Burma border. | Q47889049 | ||
| In vivo and in vitro investigations of the effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos. | Q50722178 | ||
| Recurrent miscarriage | Q56503650 | ||
| Clinical assessment of gestational age in the newborn infant | Q71466810 | ||
| Embryotoxicity and teratogenicity studies on artemether in mice, rats and rabbits | Q72821278 | ||
| Enrolling pregnant women in research--lessons from the H1N1 influenza pandemic | Q30390398 | ||
| Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study | Q33528929 | ||
| Arthropod borne disease: the leading cause of fever in pregnancy on the Thai-Burmese border | Q33754684 | ||
| Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia | Q34149822 | ||
| Conception, early pregnancy loss, and time to clinical pregnancy: a population-based prospective study | Q34181788 | ||
| Malaria in pregnancy: the difficulties in measuring birthweight | Q35054459 | ||
| Estimation of gestational age from fundal height: a solution for resource-poor settings | Q35684073 | ||
| Obstetric ultrasound scanning by local health workers in a refugee camp on the Thai-Burmese border | Q36225491 | ||
| Review: Hyperthermia and fever during pregnancy | Q36577751 | ||
| The effects of quinine and chloroquine antimalarial treatments in the first trimester of pregnancy | Q39234325 | ||
| Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study | Q39309831 | ||
| Effects of Plasmodium vivax malaria in pregnancy | Q39309842 | ||
| Malaria during pregnancy in an area of unstable endemicity | Q39309866 | ||
| Oral artesunate in the treatment of uncomplicated hyperparasitemic falciparum malaria | Q40678753 | ||
| The epidemiology of severe malaria in an area of low transmission in Thailand | Q41928473 | ||
| Selective toxicity of dihydroartemisinin on human CD34+ erythroid cell differentiation | Q42945274 | ||
| Correction to 'Estimation of gestational age from fundal height: a solution for resource-poor settings'. | Q43096324 | ||
| The Thai-Burmese border: drug studies of Plasmodium falciparum in pregnancy | Q43506299 | ||
| Association of DDT with spontaneous abortion: a case-control study. | Q43737588 | ||
| P433 | issue | 5 | |
| P921 | main subject | malaria | Q12156 |
| Plasmodium vivax | Q311376 | ||
| Plasmodium falciparum | Q311383 | ||
| antimalarial | Q521616 | ||
| pregnancy-associated malaria | Q7239883 | ||
| P304 | page(s) | 388-396 | |
| P577 | publication date | 2011-12-12 | |
| P1433 | published in | Lancet Infectious Diseases | Q15724248 |
| P1476 | title | Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study | |
| P478 | volume | 12 |
| Q17485688 | A systematic review of the safety and efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria during pregnancy |
| Q91996548 | An information-motivation-behavioural skills analysis of long-lasting insecticidal net use among pregnant women in a hospital in North-Eastern Nigeria |
| Q56428696 | Animal Embryotoxicity Studies of Key Non-Artemisinin Antimalarials and Use in Women in the First Trimester |
| Q64107927 | Artemisinin-based combination therapy during pregnancy: outcome of pregnancy and infant mortality: a cohort study |
| Q60680568 | Artemisinins—a Promising New Treatment for Systemic Lupus Erythematosus: a Descriptive Review |
| Q28393215 | Artesunate overcomes drug resistance in multiple myeloma by inducing mitochondrial stress and non-caspase apoptosis |
| Q36348696 | Assessment of the safety of antimalarial drug use during early pregnancy (ASAP): protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique |
| Q94601988 | Association of Angiopoietin Dysregulation in Placental Malaria with Adverse Birth Outcomes |
| Q33825631 | Burden and impact of Plasmodium vivax in pregnancy: A multi-centre prospective observational study |
| Q38264242 | Burden of malaria in early pregnancy: a neglected problem? |
| Q38207464 | Clinical focus: infections in pregnancy |
| Q99569236 | Deleterious effects of malaria in pregnancy on the developing fetus: a review on prevention and treatment with antimalarial drugs |
| Q37490566 | Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy |
| Q39327919 | Dihydroartemisinin-piperaquine versus artesunate-amodiaquine for treatment of malaria infection in pregnancy in Ghana: an open-label, randomised, non-inferiority trial |
| Q46775462 | Early pregnancy exposure to feto-toxic medications among out-patients in Malawi |
| Q31119954 | Effectiveness of antenatal clinics to deliver intermittent preventive treatment and insecticide treated nets for the control of malaria in pregnancy in Kenya |
| Q64260021 | Effects of a health educational intervention on malaria knowledge, motivation, and behavioural skills: a randomized controlled trial |
| Q36915089 | Efficacy of Artesunate-mefloquine for Chloroquine-resistant Plasmodium vivax Malaria in Malaysia: An Open-label, Randomized, Controlled Trial |
| Q92830884 | Efficacy of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a protocol for systematic review and individual patient data (IPD) meta-analysis |
| Q28355357 | Epidemiology of Plasmodium vivax in Indonesia |
| Q21032494 | Evidence and implications of mortality associated with acute Plasmodium vivax malaria |
| Q56366262 | Expanding the use of primaquine for the radical cure of Plasmodium vivax |
| Q35108464 | Exposure to artemether-lumefantrine (Coartem) in first trimester pregnancy in an observational study in Zambia |
| Q33626397 | First-trimester artemisinin derivatives and quinine treatments and the risk of adverse pregnancy outcomes in Africa and Asia: A meta-analysis of observational studies |
| Q36377211 | Getting the basic rights - the role of water, sanitation and hygiene in maternal and reproductive health: a conceptual framework |
| Q30249044 | Global Epidemiology of Plasmodium vivax |
| Q34259032 | Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis |
| Q55112496 | Human Genetic Markers and Structural Prediction of Plasmodium falciparum Multidrug Resistance Gene (pfmdr1) for Ligand Binding in Pregnant Women Attending General Hospital Minna. |
| Q47123632 | IFNGR1 signaling is associated with adverse pregnancy outcomes during infection with malaria parasites |
| Q36811690 | Impact of malaria during pregnancy on pregnancy outcomes in a Ugandan prospective cohort with intensive malaria screening and prompt treatment |
| Q33748047 | Impact of maternal hepatitis B virus coinfection on mother-to-child transmission of HIV |
| Q35727968 | Imported malaria in pregnant women: A retrospective pooled analysis |
| Q24276210 | Influence of infection during pregnancy on fetal development |
| Q33820246 | Influence of the number and timing of malaria episodes during pregnancy on prematurity and small-for-gestational-age in an area of low transmission |
| Q35759333 | Intermittent presumptive treatment in pregnancy with sulfadoxine-pyrimethamine: a counter perspective |
| Q37546198 | Key Knowledge Gaps for Plasmodium vivax Control and Elimination |
| Q35500954 | Knowledge, attitudes, and practices concerning malaria in pregnancy: results from a qualitative study in Madang, Papua New Guinea |
| Q57471805 | Knowledge, motivation, self-efficacy, and their association with insecticidal net use among pregnant women in a secondary health centre in Maiduguri, Nigeria |
| Q56378965 | Malaria |
| Q56420006 | Malaria |
| Q34551791 | Malaria and fetal growth alterations in the 3(rd) trimester of pregnancy: a longitudinal ultrasound study |
| Q35678578 | Malaria and immunity during pregnancy and postpartum: a tale of two species |
| Q33815207 | Malaria caused by Plasmodium vivax: recurrent, difficult to treat, disabling, and threatening to life--the infectious bite preempts these hazards |
| Q36284603 | Malaria during Pregnancy |
| Q55435467 | Malaria during pregnancy and newborn outcome in an unstable transmission area in Brazil: A population-based record linkage study. |
| Q35712522 | Malaria eradication and elimination: views on how to translate a vision into reality |
| Q34481432 | Malaria in Pregnancy Interacts with and Alters the Angiogenic Profiles of the Placenta |
| Q56421802 | Malaria in pregnancy |
| Q34242348 | Malaria in pregnancy in the Asia-Pacific region |
| Q34433106 | Malaria: an update on current chemotherapy |
| Q34300222 | Management of imported malaria in Europe |
| Q35933939 | Mefloquine Versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment in Pregnancy: A Joint Analysis on Efficacy and Tolerability |
| Q34686612 | Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia |
| Q39279840 | Mounting evidence for use of artemisinin derivatives for malaria in early pregnancy |
| Q28468598 | New developments in anti-malarial target candidate and product profiles |
| Q35328856 | Noninferiority of glucose-6-phosphate dehydrogenase deficiency diagnosis by a point-of-care rapid test vs the laboratory fluorescent spot test demonstrated by copper inhibition in normal human red blood cells |
| Q37730159 | Oligohydramnios in a pregnant Pakistani woman with Plasmodium vivax malaria |
| Q42659378 | Pernicious and threatening Plasmodium vivax as reality |
| Q34607876 | Placental histopathological changes associated with Plasmodium vivax infection during pregnancy |
| Q33786153 | Placental infections with histologically confirmed Plasmodium falciparum are associated with adverse birth outcomes in India: a cross-sectional study |
| Q34585683 | Plasmodium falciparum malaria elicits inflammatory responses that dysregulate placental amino acid transport |
| Q31056451 | Plasmodium vivax adherence to placental glycosaminoglycans |
| Q36364248 | Population pharmacokinetic and pharmacodynamic modeling of amodiaquine and desethylamodiaquine in women with Plasmodium vivax malaria during and after pregnancy |
| Q26738398 | Postabortion Care: 20 Years of Strong Evidence on Emergency Treatment, Family Planning, and Other Programming Components |
| Q92666131 | Pregnancy-specific malarial immunity and risk of malaria in pregnancy and adverse birth outcomes: a systematic review |
| Q28596928 | Prevalence of malaria in pregnancy in southern Laos: a cross-sectional survey |
| Q48021990 | Prevalence of the Pfdhfr and Pfdhps mutations among asymptomatic pregnant women in Southeast Nigeria. |
| Q39038490 | Prevention and control of malaria in pregnancy - new threats, new opportunities? |
| Q57726668 | Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria |
| Q38408212 | Probabilistic record linkage for monitoring the safety of artemisinin-based combination therapy in the first trimester of pregnancy in Senegal |
| Q33830503 | Quantifying low birth weight, preterm birth and small-for-gestational-age effects of malaria in pregnancy: a population cohort study |
| Q36298460 | Risks of miscarriage and inadvertent exposure to artemisinin derivatives in the first trimester of pregnancy: a prospective cohort study in western Kenya |
| Q97570170 | Safety of antimalarial drugs exposure during early pregnancy |
| Q36809595 | Safety of artemisinins in first trimester of prospectively followed pregnancies: an observational study |
| Q35071971 | Severe morbidity and mortality risk from malaria in the United States, 1985-2011 |
| Q41929207 | Standby emergency treatment of malaria in travelers: experience to date and new developments |
| Q34611339 | Supplementation with multivitamins and vitamin A and incidence of malaria among HIV-infected Tanzanian women |
| Q36261056 | Syncytiotrophoblast Functions and Fetal Growth Restriction during Placental Malaria: Updates and Implication for Future Interventions |
| Q47244112 | Systematic literature review and meta-analysis of the efficacy of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: methodological challenges |
| Q54217436 | The Hidden Burden of Plasmodium vivax Malaria in Pregnancy in the Amazon: An Observational Study in northwestern Brazil. |
| Q36185610 | The Safety of Artemisinin Derivatives for the Treatment of Malaria in the 2nd or 3rd Trimester of Pregnancy: A Systematic Review and Meta-Analysis. |
| Q36048672 | The epidemiology of postpartum malaria: a systematic review |
| Q26783142 | The role of infection in miscarriage |
| Q36583907 | Timing of malaria in pregnancy and impact on infant growth and morbidity: a cohort study in Uganda |
| Q28691509 | Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia |
| Q28607891 | Towards a strategy for malaria in pregnancy in Afghanistan: analysis of clinical realities and women's perceptions of malaria and anaemia |
| Q34456393 | Treating severe malaria in pregnancy: a review of the evidence |
| Q48507549 | Treatment of uncomplicated and severe malaria during pregnancy. |
| Q38870452 | Treatment regimens for pregnant women with falciparum malaria |
| Q28732159 | Ultrasound evidence of early fetal growth restriction after maternal malaria infection |
| Q42712939 | Use of artemether-lumefantrine to treat malaria during pregnancy: what do we know and need to know? |
| Q36819165 | Weekly miscarriage rates in a community-based prospective cohort study in rural western Kenya |
| Q49339210 | When Epidemiology Is the Clue to a Positive Outcome: A Case of Malaria During Pregnancy |
Search more.